China IPO Frenzy: CXMT DRAM Titan Faces Oligopoly Test While Two Peers Hit Listing Hurdles

The Quick Take

• CXMT (长鑫存储), China's DRAM champion, faces analyst scrutiny on whether it can sustain super-cycle gains against the Samsung-SK Hynix-Micron oligopoly
• Huangguan New Materials IPO review raises concerns: revenue growth trails the sector while gross margin moves counter to industry trend
• Lao Xiang Ji's Hong Kong IPO prospectus has lapsed, with the company saying its listing work continues as regulated
• Research analysts are for the first time benchmarking CXMT on a global DRAM competitive axis rather than only a domestic one

China's IPO market is simultaneously celebrating and stress-testing three listings at very different stages. CXMT, the country's first homegrown DRAM memory champion, has triggered retail IPO subscription frenzy while analysts for the first time place it in a global competitive frame against the Samsung-SK Hynix-Micron oligopoly that has dominated DRAM markets for over a decade. Two other Chinese companies — specialty materials firm Huangguan New Materials and restaurant chain Lao Xiang Ji — are navigating more turbulent IPO paths, illustrating the uneven state of Chinese equity market access for industries outside the favored semiconductor and advanced technology sectors.

CXMT's IPO has ignited debate about the durability of its memory super-cycle advantage. The company benefited from an extraordinary alignment of global DRAM demand recovery, AI infrastructure buildout and China's domestic tech investment push. Peer pressure from Samsung's manufacturing scale and SK Hynix's HBM dominance limits CXMT's addressable market in the highest-margin segments. The IPO frenzy, while validating investor confidence, raises valuation risk: if DRAM prices soften before CXMT's capacity ramp completes, retail investors who subscribed at peak enthusiasm face sharp mark-to-market losses in early secondary trading after listing.

Watch CXMT's first-day secondary market premium or discount to offering price as the primary signal of how robustly retail IPO enthusiasm converts to durable institutional demand. The Huangguan New Materials CSRC approval committee review date will reveal how strictly regulators are applying profitability screens in the current IPO cycle. For Lao Xiang Ji, whether its Hong Kong listing re-submits within the 90-day window matters for the consumer sector's offshore funding access. The key macro variable: any tightening of US semiconductor sanctions on Chinese firms directly threatens CXMT's ability to source Western equipment for capacity expansion at scale.

Synthesized from 3 sources.